Latest Breaking News On - Pegylated interferon - Page 7 : comparemela.com

Cadila Health gains after DGCI approves Virafin for moderate COVID-19 cases

Cadila Healthcare added 2.87% to Rs 568.10 after the company received emergency use approval from India s drug regulator for the use of Pegylated Interferon alpha-2b, Virafin in treating moderate COVID-19 infection in adults. A single dose subcutaneous regimen of the antiviral Virafin will make the treatment more convenient for the patients. When administered early on during COVID, Virafin will help patients recover faster and avoid much of the complications. Virafin will be available on the prescription of medical specialist for use in hospital/institutional setup. In the multicentric trial conducted in 20-25 centers across India, Virafin had shown lesser need for supplemental oxygen, clearly indicating that it was able to control respiratory distress and failure which has been one of the major challenges in treating COVID-19. The drug has also shown efficacy against other viral infections.

Sharvil patelCadila healthcarePegylated interferonCapital marketAntiviral drugsMedical specialtiesCompanies based in ahmedabadPegylated interferonCadila healthcareCadila pharmaceuticalsCovid 19Generic pharmaceuticalsஷார்வில் படேல்காடிலா சுகாதாரம்மூலதனம் சந்தை

Todays News Headlines - 23 Apr, 2021 | Times of India

Today s News Headlines The government on Friday announced to provide 5 kg free food grains to the poor for May and June 2021. This will cover nearly 80 crore beneficiaries under the National Food Security Act (NFSA). Each beneficiary under NFSA will get 5 kg per person per month for the next two months and this will be over and above their entitlement of 5 kg of rice, wheat and coarse grains at Rs 3, 2 and Re 1 per kg respectively. The government said this will be rolled out on the same pattern as last year’s PM Garib Kalyan Yojana. The Centre would spend more than Rs 26,000 crore on this initiative. Read more

Madhya pradeshUttar pradeshDushyant daveZydus cadilaNarendra modiZydus cadila virafinSuneet sharmaSupreme courtPegylated interferonDrug controller generalChief justiceArvind kejriwalPrime minister narendraPrime ministerOxygen expresChairman suneet sharma

Zydus receives emergency use approval for Covid drug Virafin

Zydus receives emergency use approval for Covid drug Virafin By IANS | 25 Views Zydus receives emergency use approval for Covid drug Virafin . Image Source: IANS News Ahmedabad, April 23 : Zydus Cadila on Friday announced it has received restricted Emergency Use Approval from the Drug Controller General of India (DCGI) for the use of antiviral Virafin in treating moderate Covid-19 infection in adults. The single dose subcutaneous regimen of the anti-viral drug reduced the need for supplemental oxygen, indicating that it was able to control respiratory distress and failure one of the major challenges in treating Covid-19, according to results of a multicentric trial conducted in 20-25 centres across India.

Sharvil patelCadila healthcare ltdZydus cadilaEmergency use approvalDrug controller generalManaging directorPegylated interferonஷார்வில் படேல்காடிலா சுகாதாரம் லிமிடெட்ஜய்துச் காடிலாஅவசரம் பயன்பாடு ஒப்புதல்மருந்து கட்டுப்படுத்தி ஜநரல்நிர்வகித்தல் இயக்குனர்

Nifty, Sensex may try to head higher – Weekly closing report

Nifty, Sensex may try to head higher – Weekly closing report Moneylife Digital Team 0 We had mentioned in last week’s closing report that Nifty, Sensex were indecisive. The major indices continued to fall and ended in losses. The trend of the major indices in the week is given in the table: On Monday, the indices opened lower and suffered a major correction. On the NSE, there were 379 advances, 1,595 declines and 68 unchanged. Jubilant Pharmova has developed a novel oral formulation of Remdesivir, which, the company said, is likely to ease the capacity constraint that injectable formulation faces and ensure wider and timely availability for COVID-19 patients.

Saudi arabiaTata elxsiZydus cadilaLarsen toubroCreditaccess grameenOilfields supply company saudiMoneylife digital teamDr reddy labsPower grid corporationGlobal access fundTrip plannersHousing financeAccess grameenReserve bankGrid corporationPegylated interferon

Cadila Healthcare s Hepatitis C drug gets approval for emergency use

Cadila Healthcare s Hepatitis C drug gets approval for emergency use
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Sharvil patelCadila healthcareManaging direcPegylated interferonஷார்வில் படேல்காடிலா சுகாதாரம்